CompletedNot Applicable

Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)

Portugal65 participantsStarted 2015-01

Plain-language summary

The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Spontaneous Intracerebral Hemorrhage * ICU admission * Need of Sedation and Ventilatory Support * Need of Intracerebral Neuromonitoring Exclusion Criteria: * Etiology for Intracerebral hemorrhage such as tumor, vascular malformation, ischemic transformation.

What they're measuring

Survival

Timeframe: 1 and 6 months

Functional Outcome

Timeframe: 6 month

Trial details

NCT IDNCT05501613

SponsorUniversidade do Porto

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-01

View on ClinicalTrials.gov More Intracerebral Hemorrhage trials